Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.

Summary

The purpose of this project is to assess the safety and effectiveness of fondaparinux, a new drug to prevent blood clotting in the continuous dialysis machine used in intensive care patients who have kidney failure.

Timeline

Start

2004-06

Primary completion

2007-12

Completion

2007-12

Outcome

Outcome not reported

Stopped: “Teh Priincipal investigator responsible for the trial no longer employed at the study site.”

Drugs

Indications